Stay updated on Avelumab first-line maintenance in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page.

Latest updates to the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check16 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.5%
- Check23 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check60 days agoChange DetectedThe page has been updated to include new drug information and a revision number, while significant details about the study's purpose and inclusion/exclusion criteria have been removed.SummaryDifference11%
Stay in the know with updates to Avelumab first-line maintenance in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page.